ENDRA Life Sciences (NDRA) Cost of Revenue (2016 - 2017)
ENDRA Life Sciences (NDRA) posted quarterly Cost of Revenue of $3085.0 for Q4 2017, down 98.69% year-over-year from $235878.0 in Q4 2016, and down 97.39% quarter-over-quarter from $118270.0 in Q3 2017.
ENDRA Life Sciences (NDRA) Cost of Revenue (2016 - 2017) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Cost of Revenue for 2 consecutive years, with $3085.0 the latest figure, recorded in Q4 2017.
- In Q4 2017, Cost of Revenue fell 98.69% year-over-year to $3085.0; the TTM figure through Sep 2018 stood at $3085.0 (down 99.24% YoY), while the FY2017 annual figure was $172782.0, down 26.75% from the prior year.
- Cost of Revenue declined to $3085.0 in Q4 2017 per NDRA's latest filing, from $118270.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $235878.0 in Q4 2016 and bottomed at $3085.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.78 Bn | 209.71 Bn | 8.34 Bn | 3.65 Bn |
| 2 | Danaher | 139.83 Bn | 135.48 Bn | 3.61 Bn | 2.65 Bn |
| 3 | Idexx Laboratories | 45.99 Bn | 45.79 Bn | 779.09 Mn | 437.50 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 845.00 Mn |
| 5 | Iqvia Holdings | 39.31 Bn | 37.23 Bn | 1.44 Bn | 2.93 Bn |
| 6 | Natera | 38.74 Bn | 37.64 Bn | 696.04 Mn | 608,000.00 |
| 7 | Illumina | 29.94 Bn | 28.77 Bn | 770.00 Mn | 389.00 Mn |
| 8 | Mettler Toledo International | 28.55 Bn | 28.50 Bn | 650.22 Mn | 253.28 Mn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 2.02 Bn |
| 10 | ENDRA Life Sciences | 5.48 Mn | 5.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 3,085.00 |
| Dec 31, 2017 | 3,085.00 |
| Sep 30, 2017 | 118,270.00 |
| Sep 30, 2017 | 118,270.00 |
| Jun 30, 2017 | 51,427.00 |
| Jun 30, 2017 | 51,427.00 |
| Dec 31, 2016 | 235,878.00 |
| Dec 31, 2016 | 235,878.00 |